Abstract:Background: Although cannabis use incidence, societal acceptance, and legislation all trend positively, cannabis remains federally illegal in the USA. Prior studies have revealed that patients are reluctant to disclose their cannabis use history in the healthcare system, which can negatively impact patient care. This study reports the frequency of cannabis use disclosure with special considerations for stigmatization. To better understand the limitations, providers face in providing collaborative, comprehensive, and informed care, this study evaluated four domains of stigma: perceived, anticipated, enacted, and internalized. Methods: This study used a descriptive exploratory design. Data collection occurred using an anonymous, online national survey with a convenience sample in the USA. Recruitment relied on electronic media and occurred between July and December 2022. Participants were adults older than 21 years and self-identified as having used cannabis and accessed the healthcare system within the last five years. The survey measured demographic characteristics, cannabis use, and disclosure patterns. Stigma was measured using the Stigma Use Stigma Mechanism Scale (SU-SMS) and Substance Abuse Use Self-Stigma Scale (SASSS) with language modifications for cannabis. Ordinal logistic regression models were performed to evaluate associations between the frequency of cannabis use disclosure patterns and each stigma category. Associations were assessed using Chi-squared or Fisher's exact tests. Results: Data were available for 249 respondents. Most participants (57.1%) reported initiating a conversation about cannabis with their healthcare provider; 27.8% of the time, cannabis is never discussed, and healthcare providers initiate only 15.1% of related discussions. Anticipated stigma [95% CI 1.045-1.164] and total stigma [95% CI 1.001-1.039] had statistically significant associations with nondisclosure. Annual household income (p = .04), chronicity of cannabis use (p = .03), frequency of cannabis use (p = .02), and a known amount of CBD in products consumed (p = .01) had statistically significant associations with the frequency of cannabis use disclosure. Conclusions: Patients who use cannabis experience stigmatization in the healthcare setting that may limit disclosure of cannabis use history. Future studies would be well served to explore anticipated stigma more deeply. Healthcare providers should be knowledgeable to lead such conversations relating to cannabis while maintaining an unbiased perspective.

Examining the Relationship between Culture and Perceived Societal Substance Use Stigma in a Michigan-Based Mental Health & Addiction Focused Community

Perceptions of structural and provider-based substance use stigma interventions among primary care professionals

Exploring perceptions of self-stigma of substance use and current alcohol and marijuana use patterns among college students

Persistence of stigma and the cessation of substance use: comparing stigma domains between those who currently use and those who no longer use substances

Stigma Toward Substance Dependence: Causes, Consequences, and Potential Interventions

Fear of Stigma Mediates the Relationship between Internalized Stigma and Treatment-Seeking among Individuals with Substance Use Problems

Public Stigma on Substance Users in China

Individual, interpersonal, and neighborhood measures associated with opioid use stigma: Evidence from a nationally representative survey

Contact reduces substance use stigma through bad character attributions, especially for U.S. health care professionals.

"I am not a junkie": Social categorization and differentiation among people who use drugs

Substance Use Disorder Stigma and Professional Decision Making Among Pre-Professional Healthcare Trainees

Opioid Use Disorder Stigma Reduction Through Story Telling Narrative and Sharing: a Qualitative Review and Lessons Learned

Removing Stigmatizing Language in Self-Reports: Effects on Psychometric Properties and Respondent Beliefs

Lived Experience Matters: Automatic Detection of Stigma on Social Media Toward People Who Use Substances

“We Weren’t Raised that Way”: Using Stigma Management Communication Theory to Understand How Families Manage the Stigma of Substance Abuse

Negative attitudes about medications for opioid use disorder among criminal legal staff

Perceptions of stigma among people with lived experience of methamphetamine use within the hospital setting: qualitative point-in-time interviews and thematic analyses of experiences

Problematic smartphone use and two types of problematic use of the internet and self-stigma among people with substance use disorders

The role of stigma in cannabis use disclosure: an exploratory study

“A scarlet letter”: Stigma and other factors affecting trust in the health care system for women seeking substance abuse treatment in a community setting

Examining the relationship between public stigma, models of addiction, and addictive disorders